Minh Patrick Lê (Minh P Lê, Minh-Patrick Le, Minh Patrick Le)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Topics

Intensive Care Unit

Peritoneal Dialysis

Hiv Infected Patients

Respiratory Syndrome Coronavirus

Top Venues

The Journal of antimicrobial chemotherapy

British journal of clinical pharmacology

Antimicrobial agents and chemotherapy

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra Duhant, Byabene Kusinza, Claire Tantet, Basimane Bisimwa, Mathilde Gare, Bihehe Masemo, Chakib Alloui, Mukanire Ntakwinjan, Frédéric Mechai, Minh Patrick Lê, Athenaïs Gerber, Balthazar Muhigirwa, Gilles Peytavin, Emmanuel Gordien, Ségolène Brichler, Mukengere Mukwege, Frédéric Le Gal
HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals. The Journal of antimicrobial chemotherapy (2023)
Florian Lemaitre, Jennifer Lagoutte-Renosi, Marie-Claude Gagnieu, François Parant, Nicolas Venisse, Matthieu Gregoire, Stéphane Bouchet, Rodolphe Garraffo, Minh Patrick Lê, Patrice Muret, Emmanuelle Comets, Caroline Solas, Gilles Peytavin, null null
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1 infected-patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER Study). British journal of clinical pharmacology (2023)
Sihem Benaboud, Caroline Solas, Stephane Bouchet, Matthieu Gregoire, Florian Lemaitre, Nicolas Venisse, Minh Patrick Lê, Patrice Muret, Francois Parant, Nadege Neant, Sana Boujafaar, Jennifer Lagoutte-Renosi, Rodolphe Garraffo, Gilles Peytavin
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Sihem Benaboud, Caroline Solas, Stephane Bouchet, Matthieu Gregoire, Florian Lemaitre, Nicolas Venisse, Minh Patrick Lê, Patrice Muret, Francois Parant, Nadege Neant, Sana Boujafaar, Jennifer Lagoutte-Renosi, Rodolphe Garraffo, Gilles Peytavin
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV. The Journal of antimicrobial chemotherapy (2023)
Romain Palich, Basma Abdi, Marc Wirden, Giota Lourida, Roland Tubiana, Antoine Faycal, Marc-Antoine Valantin, Luminita Schneider, Sophie Seang, Rachid Agher, Anne Simon, Cathia Soulie, Minh Patrick Lê, Gilles Peytavin, Vincent Calvez, Anne-Geneviève Marcelin, Christine Katlama
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients. The Journal of antimicrobial chemotherapy 76 (7) (2021)
Minh Patrick Lê, Valentine Marie Ferré, Fabienne Mazy, Agnès Bourgeois-Moine, Florence Damond, Sophie Matheron, Diane Descamps, Jade Ghosn, Gilles Peytavin
Bictegravir pharmacokinetics in a late-presenting HIV-1-infected pregnant woman: a case report. The Journal of antimicrobial chemotherapy (2021)
Minh Patrick Lê, Lucile Pencolé, Gilles Peytavin, Florian Bouchet-Crivat, Laurent Mandelbrot
Placental transfer of doravirine, a recent HIV-1 NNRTI in the ex vivo human cotyledon perfusion model. The Journal of antimicrobial chemotherapy 76 (9) (2021)
Nadège Néant, Minh Patrick Lê, Naïm Bouazza, Florence Gattacceca, Yazdan Yazdanpanah, Catherine Dhiver, Sylvie Bregigeon, Saadia Mokhtari, Gilles Peytavin, Catherine Tamalet, Diane Descamps, Bruno Lacarelle, Caroline Solas
Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV-infected patients. British journal of clinical pharmacology 86 (12) (2020)
Dominique Vodovar, Minh Patrick Lê, Laurence Labat, Bruno Mégarbane
Identifying lithium-poisoned patients who may benefit from haemodialysis remains highly challenging. British journal of clinical pharmacology 86 (12) (2020)
Jean-François Timsit, Elodie Gautier-Veyret, Minh Patrick Lê, Lila Bouadma, Olivier Andremont, Mathilde Neuville, Bruno Mourvillier, Romain Sonneville, Eric Magalhaes, Jordane Lebut, Aguila Radjou, Roland Smonig, Michel Wolff, Laurent Massias, Claire Dupuis, Jean François Timsit
Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study. Antimicrobial agents and chemotherapy 64 (12) (2020)
Minh Patrick Lê, Quentin Le Hingrat, Pierre Jaquet, Paul-Henri Wicky, Vincent Bunel, Laurent Massias, Benoit Visseaux, Jonathan Messika, Diane Descamps, Hervé Mal, Jean-François Timsit, Gilles Peytavin
Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19. Antimicrobial agents and chemotherapy 64 (11) (2020)
Minh Patrick Lê, Christine Le Beller, Quentin Le Hingrat, Pierre Jaquet, Paul-Henri Wicky, Vincent Bunel, Laurent Massias, Benoit Visseaux, Jonathan Messika, Diane Descamps, Hervé Mal, Jean François Timsit, Gilles Peytavin
Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity". Antimicrobial agents and chemotherapy 64 (12) (2020)
Minh Patrick Lê, Marc-Antoine Valantin, Lambert Assoumou, Cathia Soulie, Soizic Le Mestre, Laurence Weiss, Yazdan Yazdanpanah, Jean-Michel Molina, Olivier Bouchaud, François Raffi, Jacques Reynes, Vincent Calvez, Anne-Geneviève Marcelin, Dominique Costagliola, Christine Katlama, Gilles Peytavin, null null
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS-163 ETRAL Study. Pharmacotherapy 39 (4) (2019)
Minh Patrick Lê, Marie-Laure Chaix, François Raffi, Sylvie Chevret, Sébastien Gallien, Christine Katlama, Pierre Delobel, Yazdan Yazdanpanah, Juliette Saillard, Jean-Michel Molina, Gilles Peytavin, null null
Once-daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS-165 DARULIGHT study. British journal of clinical pharmacology 85 (1) (2018)